Schedule 13G ownership disclosure
Millendo Therapeutics, Inc.
Security class unavailable · CUSIP: 60040X103
Event date: 2018-12-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 678,532
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-073347
- Form type
- SC 13G
- Filer
- Tempest Therapeutics, Inc.
- CIK
- CIK 1544227
- Filed
- Dec 17, 2018
- Reporting period
- Dec 07, 2018
- Description
- Schedule 13G beneficial ownership